2.5 tirzepatide weight loss Retatrutide vs (2026): Differences in Loss, Metabol – Revolution Health & Wellness Mounjaro (tirzepatide) - Diabetes &

Both classes of drugs demonstrated kidney benefit

Based on available Phase 2 data, both agents share a side-effect profile broadly consistent with other medicines acting on metabolic hormone pathways, though the triple-agonist mechanism of retatrutide introduces some additional considerations

It is also approved for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver scarring as well as to lower the risk of heart attack, stroke, and death from heart disease in adults with heart disease and overweight or obesity

You are not required to begin treatment immediately, and there is no obligation to move forward before you feel ready

Diarrhea or Constipation An upset stomach equals frequent trips to the bathroom